Acerola is a tropical fruit and dietary supplement rich in vitamin C and plant pigments, used to maintain vitamin C levels and support skin, immune, and blood-sugar health. Longevity advantages over synthetic oral vitamin C remain unconfirmed, as human studies used blended products or lacked controls. Moderate doses are well tolerated; high doses can cause loose stools, kidney stones in men, or iron overload. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Fasting Plasma Ascorbic Acid | ≥ 50–70 µmol/L | Confirms systemic vitamin C repletion and tissue saturation |
| 24-Hour Urinary Oxalate | < 40 mg/24 hours | Detects hyperoxaluria requiring dose reduction or cessation |
| Serum Ferritin and Transferrin Saturation | Ferritin 30–300 ng/mL (men), 15–150 ng/mL (women); transferrin saturation 20–45% | Screens for latent iron overload that contraindicates high-dose ascorbate |
| Fasting Serum Glucose, Urea, ALT, and AST | Glucose 3.9–5.5 mmol/L; urea 2.5–7.1 mmol/L; ALT 0.17–0.68 µkat/L; AST 0.17–0.60 µkat/L | Tracks metabolic and hepatic enzyme reductions seen with acerola supplementation |
| Complete Blood Count (Hemoglobin, Neutrophils, Platelets) | Hemoglobin 135–175 g/L (men), 120–155 g/L (women); neutrophils 1.8–7.5 × 10⁹/L; platelets 150–400 × 10⁹/L | Monitors for mild reductions in hemoglobin, neutrophils, and platelets at high doses |
Cadence: Baseline before starting supplementation, follow-up at 4 weeks and 12 weeks, then every 6 to 12 months during long-term maintenance.